Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
7.28
+0.03 (0.41%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Tempest Therapeutics Market Cap
Tempest Therapeutics has a market cap or net worth of $25.47 million as of April 17, 2025. Its market cap has decreased by -77.61% in one year.
Market Cap
25.47M
Enterprise Value
10.57M
1-Year Change
-77.61%
Ranking
Category
Stock Price
$7.28
Market Cap Chart
Since June 28, 2021, Tempest Therapeutics's market cap has decreased from $88.65M to $25.47M, a decrease of -71.27%. That is a compound annual growth rate of -27.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2025 | 25.47M | -30.06% |
| Dec 31, 2024 | 36.42M | -57.00% |
| Dec 29, 2023 | 84.69M | 600.22% |
| Dec 30, 2022 | 12.09M | -66.85% |
| Dec 31, 2021 | 36.49M | -58.84% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 666.36B |
| UnitedHealth Group | 541.28B |
| Johnson & Johnson | 372.92B |
| AbbVie | 306.62B |
| Novo Nordisk | 286.28B |
| Abbott Laboratories | 231.83B |
| AstraZeneca | 210.97B |
| Novartis AG | 209.02B |